| VRTX | Vertex Pharmaceuticals Inc | $111.13B | +41705.33% |
| VRNA | Verona Pharma Plc | $77.75B | +29148.50% |
| REGN | Regeneron Pharmaceuticals Inc | $65.28B | +24460.14% |
| ARGX | Argen X SE | $54.32B | +20336.35% |
| ALNY | Alnylam Pharmaceuticals Inc | $39.13B | +14622.29% |
| ONC | BeiGene Ltd | $34.73B | +12966.36% |
| RVMD | Revolution Medicines Inc | $30.63B | +11421.97% |
| RPRX | Royalty Pharma plc - Class A | $23.57B | +8768.35% |
| BNTX | BioNTech SE | $23.52B | +8747.54% |
| INSM | Insmed Inc | $23.04B | +8566.85% |
| ROIV | Roivant Sciences Ltd | $21.31B | +7916.06% |
| INCY | Incyte Corp | $19.46B | +7221.95% |
| MRNA | Moderna Inc | $18.90B | +7010.60% |
| GMAB | Genmab | $17.06B | +6316.37% |
| ASND | Ascendis Pharma A/S | $15.18B | +5610.49% |
| JAZZ | Jazz Pharmaceuticals plc | $14.70B | +5431.99% |
| SMMT | Summit Therapeutics Inc | $13.47B | +4968.03% |
| BBIO | BridgeBio Pharma Inc | $13.00B | +4791.65% |
| EXEL | Exelixis Inc | $12.69B | +4674.97% |
| IONS | Ionis Pharmaceuticals Inc | $12.69B | +4673.91% |
| MDGL | Madrigal Pharmaceuticals Inc | $12.16B | +4474.03% |
| AXSM | Axsome Therapeutics Inc | $12.06B | +4436.63% |
| ARWR | Arrowhead Pharmaceuticals Inc | $11.10B | +4077.20% |
| ABVX | Abivax | $10.29B | +3769.75% |
| BMRN | Biomarin Pharmaceutical Inc | $10.12B | +3708.42% |
| PRAX | Praxis Precision Medicines Inc | $9.95B | +3642.98% |
| CYTK | Cytokinetics Inc | $9.51B | +3477.85% |
| KRYS | Krystal Biotech Inc | $9.03B | +3295.67% |
| NUVL | Nuvalent Inc - Class A | $8.45B | +3077.99% |
| IBRX | ImmunityBio Inc | $8.26B | +3008.73% |
| HALO | Halozyme Therapeutics Inc | $8.14B | +2960.98% |
| TECH | Bio-Techne Corp | $7.53B | +2731.60% |
| MTSR | Metsera Inc | $7.40B | +2685.62% |
| PCVX | Vaxcyte Inc | $7.36B | +2669.93% |
| CORT | Corcept Therapeutics Inc | $6.96B | +2518.57% |
| MRUS | Merus N.V | $6.83B | +2467.82% |
| IMVT | Immunovant Inc | $6.81B | +2463.29% |
| KYMR | Kymera Therapeutics Inc | $6.71B | +2425.90% |
| ACLX | Arcellx Inc | $6.67B | +2407.72% |
| PTGX | Protagonist Therapeutics Inc | $6.56B | +2369.61% |
| CDTX | Cidara Therapeutics Inc | $6.49B | +2343.14% |
| CELC | Celcuity Inc | $6.48B | +2336.68% |
| RYTM | Rhythm Pharmaceuticals Inc | $6.26B | +2253.97% |
| CNTA | Centessa Pharmaceuticals plc | $6.15B | +2214.97% |
| SRRK | Scholar Rock Holding Corp | $6.03B | +2169.01% |
| TGTX | TG Therapeutics Inc | $6.00B | +2157.68% |
| MIRM | Mirum Pharmaceuticals Inc | $5.93B | +2130.84% |
| COGT | Cogent Biosciences Inc | $5.89B | +2117.09% |
| PTCT | PTC Therapeutics Inc | $5.86B | +2103.19% |
| APGE | Apogee Therapeutics Inc | $5.82B | +2090.27% |
| SYRE | Spyre Therapeutics Inc | $5.72B | +2050.61% |
| BLTE | Belite Bio Inc | $5.59B | +2002.88% |
| CGON | Cg Oncology Inc | $5.35B | +1912.99% |
| LEGN | Legend Biotech Corp | $5.26B | +1880.65% |
| APLS | Apellis Pharmaceuticals Inc | $5.25B | +1874.55% |
| XENE | Xenon Pharmaceuticals Inc | $5.21B | +1859.26% |
| CRSP | CRISPR Therapeutics AG | $5.16B | +1841.01% |
| DNTH | Dianthus Therapeutics Inc | $4.73B | +1679.68% |
| LGND | Ligand Pharmaceuticals Inc - Class B | $4.72B | +1677.41% |
| FOLD | Amicus Therapeutics Inc | $4.50B | +1594.50% |
| TVTX | Travere Therapeutics Inc | $4.41B | +1560.24% |
| AKRO | Akero Therapeutics Inc | $4.38B | +1547.81% |
| CAI | Caris Life Sciences Inc - Class A | $4.35B | +1535.40% |
| NAMS | NewAmsterdam Pharma Company NV | $4.26B | +1504.27% |
| ERAS | Erasca Inc | $3.88B | +1358.06% |
| CRNX | Crinetics Pharmaceuticals Inc | $3.87B | +1357.58% |
| CPRX | Catalyst Pharmaceuticals Inc | $3.83B | +1339.61% |
| VKTX | Viking Therapeutics Inc | $3.67B | +1280.35% |
| ACAD | Acadia Pharmaceuticals Inc | $3.63B | +1263.84% |
| EWTX | Edgewise Therapeutics Inc | $3.60B | +1256.17% |
| TLX | Telix Pharmaceuticals Ltd | $3.30B | +1141.34% |
| BEAM | Beam Therapeutics Inc | $3.28B | +1132.59% |
| DNLI | Denali Therapeutics Inc | $3.21B | +1106.26% |
| RCUS | Arcus Biosciences Inc | $3.01B | +1031.70% |
| DYN | Dyne Therapeutics Inc | $3.00B | +1028.62% |
| ORKA | ARCA biopharma Inc | $2.91B | +994.45% |
| TNGX | Tango Therapeutics Inc | $2.83B | +965.69% |
| GPCR | Structure Therapeutics Inc | $2.81B | +957.15% |
| SLNO | Soleno Therapeutics Inc | $2.74B | +931.38% |
| RLAY | Relay Therapeutics Inc | $2.73B | +927.13% |
| ALMS | Alumis Inc | $2.67B | +903.45% |
| IRON | Disc Medicine Inc | $2.66B | +902.26% |
| ARQT | Arcutis Biotherapeutics Inc | $2.64B | +894.91% |
| TARS | Tarsus Pharmaceuticals Inc | $2.58B | +872.05% |
| IDYA | Ideaya Biosciences Inc | $2.57B | +867.75% |
| ELVN | Enliven Therapeutics Inc | $2.52B | +848.56% |
| IMNM | Immunome Inc | $2.50B | +841.33% |
| MLYS | Mineralys Therapeutics Inc | $2.47B | +830.89% |
| VERA | Vera Therapeutics Inc - Class A | $2.45B | +821.50% |
| ETNB | 89bio Inc | $2.34B | +781.41% |
| RARE | Ultragenyx Pharmaceutical Inc | $2.30B | +764.97% |
| DAWN | Day One Biopharmaceuticals Inc | $2.22B | +734.12% |
| KOD | Kodiak Sciences Inc | $2.18B | +720.51% |
| CLDX | Celldex Therapeutics Inc | $2.11B | +692.62% |
| ZLAB | Zai Lab Ltd | $2.08B | +680.62% |
| AUPH | Aurinia Pharmaceuticals Inc | $2.03B | +664.50% |
| MESO | Mesoblast Ltd | $2.02B | +659.23% |
| TYRA | Tyra Biosciences Inc | $1.97B | +642.09% |
| SION | Sionna Therapeutics Inc | $1.96B | +636.46% |
| STOK | Stoke Therapeutics Inc | $1.96B | +636.39% |
| NBTX | Nanobiotix | $1.94B | +628.58% |
| AAPG | Ascentage Pharma Group International | $1.93B | +627.05% |
| PHVS | Pharvaris NV | $1.92B | +624.01% |
| IOVA | Iovance Biotherapeutics Inc | $1.91B | +620.24% |
| GLPG | Galapagos NV | $1.90B | +614.13% |
| RAPP | Rapport Therapeutics Inc | $1.89B | +610.59% |
| OCUL | Ocular Therapeutix Inc | $1.87B | +603.26% |
| TRVI | Trevi Therapeutics Inc | $1.86B | +598.05% |
| ADMA | Adma Biologics Inc | $1.84B | +592.10% |
| NVAX | Novavax Inc | $1.82B | +585.98% |
| ZYME | Zymeworks BC Inc | $1.81B | +581.75% |
| NRIX | Nurix Therapeutics Inc | $1.81B | +579.56% |
| HRMY | Harmony Biosciences Holdings Inc | $1.78B | +569.63% |
| VRDN | Viridian Therapeutics Inc | $1.77B | +565.28% |
| SRPT | Sarepta Therapeutics Inc | $1.76B | +562.46% |
| VCEL | Vericel Corp | $1.75B | +557.64% |
| OCS | Oculis Holding AG | $1.74B | +556.16% |
| SNDX | Syndax Pharmaceuticals Inc | $1.74B | +553.21% |
| BHVN | Biohaven Ltd | $1.70B | +539.24% |
| AGIO | Agios Pharmaceuticals Inc | $1.70B | +538.92% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | $1.68B | +532.80% |
| CAPR | Capricor Therapeutics Inc | $1.68B | +532.15% |
| ANAB | AnaptysBio Inc | $1.67B | +530.05% |
| PVLA | Palvella Therapeutics Inc | $1.66B | +526.04% |
| ABCL | AbCellera Biologics Inc | $1.65B | +522.03% |
| TSHA | Taysha Gene Therapies Inc | $1.65B | +521.42% |
| NUVB | Nuvation Bio Inc - Class A | $1.64B | +517.88% |
| INVA | Innoviva Inc | $1.63B | +514.47% |
| NTLA | Intellia Therapeutics Inc | $1.62B | +509.00% |
| NKTR | Nektar Therapeutics | $1.62B | +508.59% |
| GLUE | Monte Rosa Therapeutics Inc | $1.62B | +508.11% |
| QURE | uniQure N.V. | $1.59B | +496.86% |
| ATAI | ATAI Life Sciences N.V. | $1.58B | +494.11% |
| RAPT | RAPT Therapeutics Inc | $1.56B | +488.53% |
| SLS | SELLAS Life Sciences Group Inc | $1.56B | +485.30% |
| PGEN | Precigen Inc | $1.55B | +483.86% |
| IMTX | Immatics N.V | $1.53B | +476.94% |
| ARDX | Ardelyx Inc | $1.52B | +473.26% |
| MBX | MBX Biosciences Inc | $1.52B | +470.52% |
| INBX | Inhibrx Biosciences Inc | $1.50B | +466.01% |
| VIR | Vir Biotechnology Inc | $1.47B | +451.97% |
| IMCR | Immunocore Holdings plc | $1.45B | +445.39% |
| URGN | UroGen Pharma Ltd | $1.43B | +437.44% |
| BCAX | Bicara Therapeutics Inc | $1.41B | +432.14% |
| GHRS | GH Research PLC | $1.39B | +421.82% |
| KALV | KalVista Pharmaceuticals Inc | $1.37B | +416.39% |
| SEPN | Septerna Inc | $1.34B | +403.38% |
| MPLT | MapLight Therapeutics Inc | $1.34B | +402.57% |
| MLTX | MoonLake Immunotherapeutics - Class A | $1.31B | +393.63% |
| MAZE | Maze Therapeutics Inc | $1.30B | +387.43% |
| FTRE | FORTE SOFTWARE INC | $1.27B | +377.60% |
| AVBP | ArriVent BioPharma Inc | $1.24B | +368.23% |
| TRML | Tourmaline Bio Inc | $1.24B | +364.88% |
| WVE | Wave Life Sciences Ltd | $1.22B | +358.74% |
| ZBIO | Zenas Biopharma Inc | $1.13B | +324.55% |
| OLMA | Olema Pharmaceuticals Inc | $1.13B | +324.15% |
| EYPT | EyePoint Pharmaceuticals Inc | $1.10B | +313.16% |
| MNKD | Mannkind Corp | $1.10B | +312.55% |
| DBVT | DBV Technologies | $1.10B | +312.07% |
| CRVS | Corvus Pharmaceuticals Inc | $1.09B | +309.04% |
| SVRA | Savara Inc | $1.07B | +301.65% |
| JBIO | Jade Biosciences Inc | $1.06B | +299.12% |
| CVAC | CureVac N.V. | $1.05B | +294.75% |
| ANNX | Annexon Inc | $1.05B | +293.78% |
| VTYX | Ventyx Biosciences Inc | $998.72M | +275.72% |
| GRCL | Gracell Biotechnologies Inc | $989.87M | +272.39% |
| CGEM | Cullinan Oncology Inc | $953.73M | +258.79% |
| PHAR | Pharming Group N.V. | $940.58M | +253.85% |
| LXRX | Lexicon Pharmaceuticals Inc | $923.79M | +247.53% |
| ABUS | Arbutus Biopharma Corp | $913.84M | +243.78% |
| KURA | Kura Oncology Inc | $908.93M | +241.94% |
| DRTS | Alpha Tau Medical Ltd | $905.62M | +240.69% |
| ORIC | ORIC Pharmaceuticals Inc | $887.91M | +234.03% |
| JANX | Janux Therapeutics Inc | $878.90M | +230.64% |
| XNCR | Xencor Inc | $868.03M | +226.55% |
| PHAT | Phathom Pharmaceuticals Inc | $853.21M | +220.98% |
| SPRY | ARS Pharmaceuticals Inc | $844.05M | +217.53% |
| GERN | Geron Corp | $843.41M | +217.29% |
| EVMN | Evommune Inc | $841.03M | +216.39% |
| VOR | Vor Biopharma Inc | $840.96M | +216.37% |
| TBPH | Theravance Biopharma Inc | $837.63M | +215.12% |
| DRUG | Bright Minds Biosciences Inc | $834.70M | +214.01% |
| SANA | Sana Biotechnology Inc | $825.64M | +210.60% |
| MGTX | MeiraGTx Holdings plc | $805.50M | +203.03% |
| LBRX | LB Pharmaceuticals Inc | $797.16M | +199.89% |
| OMER | Omeros Corporation | $797.02M | +199.84% |
| ABSI | Absci Corp | $789.28M | +196.93% |
| CMRX | Chimerix Inc | $766.03M | +188.18% |
| RLMD | Relmada Therapeutics Inc | $761.50M | +186.48% |
| ANRO | Alto Neuroscience Inc | $714.55M | +168.81% |
| ATXS | Astria Therapeutics Inc | $709.95M | +167.08% |
| DSGN | Design Therapeutics Inc | $693.10M | +160.74% |
| SLDB | Solid Biosciences Inc | $690.73M | +159.85% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | $683.16M | +157.00% |
| CTMX | CytomX Therapeutics Inc | $675.41M | +154.09% |
| CRMD | CorMedix Inc | $663.22M | +149.50% |
| IVA | Inventiva | $655.21M | +146.49% |
| ZVRA | Zevra Therapeutics Inc | $647.31M | +143.52% |
| CABA | Cabaletta Bio Inc | $640.38M | +140.91% |
| ACRS | Aclaris Therapeutics Inc | $639.61M | +140.62% |
| PRME | Prime Medicine Inc | $596.03M | +124.23% |
| CADL | Candel Therapeutics Inc | $589.73M | +121.85% |
| CBIO | Crescent Biopharma Inc | $573.22M | +115.65% |
| TECX | AvroBio Inc | $573.01M | +115.57% |
| CLYM | Eliem Therapeutics Inc | $571.31M | +114.93% |
| ARVN | Arvinas Inc | $570.83M | +114.74% |
| ALLO | Allogene Therapeutics Inc | $550.84M | +107.22% |
| VALN | Valneva SE | $545.52M | +105.23% |
| RIGL | Rigel Pharmaceuticals | $542.79M | +104.20% |
| GYRE | Gyre Therapeutics Inc | $540.72M | +103.42% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | $538.30M | +102.51% |
| MDXG | Mimedx Group Inc | $537.64M | +102.26% |
| PRTA | Prothena Corporation plc | $532.36M | +100.28% |
| KYTX | Kyverna Therapeutics Inc | $519.97M | +95.61% |
| CTNM | Contineum Therapeutics Inc - Class A | $501.84M | +88.79% |
| XOMA | XOMA Corp | $497.12M | +87.02% |
| STRO | Sutro Biopharma Inc | $491.87M | +85.04% |
| OCGN | Ocugen Inc | $466.88M | +75.64% |
| SVA | Sinovac Biotech Ltd | $464.94M | +74.91% |
| IMMX | Immix Biopharma Inc | $462.80M | +74.10% |
| FDMT | 4D Molecular Therapeutics Inc | $462.60M | +74.03% |
| STTK | Shattuck Labs Inc | $458.03M | +72.31% |
| FULC | Fulcrum Therapeutics Inc | $451.60M | +69.89% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | $451.41M | +69.82% |
| UPB | Upstream Bio Inc | $449.51M | +69.10% |
| AUTL | Autolus Therapeutics plc | $447.12M | +68.21% |
| ADCT | Adc Therapeutics SA | $438.08M | +64.81% |
| ASMB | Assembly Biosciences Inc | $435.45M | +63.82% |
| MNPR | Monopar Therapeutics Inc | $432.42M | +62.68% |
| AURA | Aura Biosciences Inc | $430.49M | +61.95% |
| OVID | Ovid Therapeutics Inc | $424.86M | +59.83% |
| NGNE | Neoleukin Therapeutics Inc | $419.60M | +57.85% |
| IPSC | Century Therapeutics Inc | $415.14M | +56.17% |
| ZURA | Zura Bio Ltd - Class A | $408.94M | +53.84% |
| CMPX | Compass Therapeutics Inc | $408.80M | +53.79% |
| CYBN | Cybin Inc | $408.43M | +53.65% |
| AVTX | Avalo Therapeutics Inc | $403.76M | +51.90% |
| GLSI | Greenwich LifeSciences Inc | $403.22M | +51.69% |
| BNTC | Benitec Biopharma Inc | $398.51M | +49.92% |
| LYEL | Lyell Immunopharma Inc | $390.28M | +46.82% |
| YMAB | Y-Mabs Therapeutics Inc | $390.19M | +46.79% |
| CCCC | C4 Therapeutics Inc | $389.10M | +46.38% |
| VNDA | Vanda Pharmaceuticals Inc | $388.47M | +46.14% |
| ENTA | Enanta Pharmaceuticals Inc | $383.31M | +44.20% |
| RVNC | Revance Therapeutics Inc | $380.38M | +43.10% |
| XFOR | X4 Pharmaceuticals Inc | $380.11M | +43.00% |
| LXEO | Lexeo Therapeutics Inc | $377.10M | +41.87% |
| PRTC | PureTech Health plc American Depositary Shares | $376.98M | +41.82% |
| OABI | OmniAb Inc | $374.99M | +41.07% |
| REPL | Replimune Group Inc | $374.27M | +40.80% |
| ALT | Altimmune Inc | $373.67M | +40.58% |
| VSTM | Verastem Inc | $373.33M | +40.45% |
| EPRX | Eupraxia Pharmaceuticals Inc | $372.92M | +40.29% |
| PBYI | Puma Biotechnology Inc | $371.93M | +39.92% |
| LRMR | Larimar Therapeutics Inc | $365.67M | +37.56% |
| CLLS | Cellectis | $364.91M | +37.28% |
| AVIR | Atea Pharmaceuticals Inc | $364.12M | +36.98% |
| EDIT | Editas Medicine Inc | $349.39M | +31.44% |
| PALI | Palisade Bio Inc | $346.56M | +30.38% |
| RGNX | Regenxbio Inc | $345.32M | +29.91% |
| IMRX | Immuneering Corp Class A | $344.95M | +29.77% |
| FENC | Fennec Pharmaceuticals Inc | $344.37M | +29.55% |
| PRLD | Prelude Therapeutics Inc | $343.28M | +29.14% |
| FBRX | Forte Biosciences Inc | $340.15M | +27.96% |
| IMAB | I-Mab | $339.64M | +27.77% |
| NMRA | Neumora Therapeutics Inc | $334.56M | +25.86% |
| DMAC | DiaMedica Therapeutics Inc | $328.69M | +23.65% |
| LCTX | Lineage Cell Therapeutics Inc | $326.58M | +22.86% |
| RCKT | Rocket Pharmaceuticals Inc | $326.28M | +22.75% |
| NAUT | Nautilus Biotechnology Inc | $325.30M | +22.38% |
| ABEO | Abeona Therapeutics Inc | $323.57M | +21.73% |
| SLN | Silence Therapeutics Plc | $321.20M | +20.83% |
| RZLT | Rezolute Inc | $319.69M | +20.27% |
| IVVD | Invivyd Inc | $319.57M | +20.22% |
| BCYC | Bicycle Therapeutics Plc | $318.56M | +19.84% |
| ANL | Adlai Nortye Ltd | $317.46M | +19.43% |
| VTVT | vTv Therapeutics Inc - Class A | $305.06M | +14.76% |
| SCPH | scPharmaceuticals Inc | $304.59M | +14.59% |
| NAGE | Niagen Bioscience Inc | $304.32M | +14.49% |
| SRZN | Surrozen Inc | $304.03M | +14.37% |
| ARTV | Artiva Biotherapeutics Inc | $302.86M | +13.94% |
| ELDN | Eledon Pharmaceuticals Inc | $295.82M | +11.29% |
| IRD | Ocuphire Pharma Inc | $295.61M | +11.21% |
| ARMP | Armata Pharmaceuticals Inc | $289.32M | +8.84% |
| ACIU | AC Immune SA | $289.11M | +8.76% |
| ZNTL | Zentalis Pharmaceuticals Inc | $286.05M | +7.61% |
| YDES | YD Bio Ltd | $278.91M | +4.93% |
| MGNX | Macrogenics Inc | $278.39M | +4.73% |
| FATE | Fate Therapeutics Inc | $275.57M | +3.67% |
| CNTX | Context Therapeutics Inc | $273.80M | +3.00% |
| SABS | SAB Biotherapeutics Inc | $272.68M | +2.58% |
| NVCT | Nuvectis Pharma Inc | $269.23M | +1.29% |
| ALXO | Alx Oncology Holdings Inc | $263.70M | -0.80% |
| TARA | Protara Therapeutics Inc | $262.06M | -1.41% |
| CGEN | Compugen Ltd | $260.97M | -1.82% |
| TRDA | Entrada Therapeutics Inc | $257.38M | -3.17% |
| CHRS | Coherus Biosciences Inc | $256.00M | -3.69% |
| AVXL | Anavex Life Sciences Corporation | $255.77M | -3.78% |
| HUMA | Humacyte Inc | $255.32M | -3.95% |
| FHTX | Foghorn Therapeutics Inc | $250.69M | -5.69% |
| ALEC | Alector Inc | $245.37M | -7.69% |
| LENZ | LENZ Therapeutics Inc | $242.37M | -8.82% |
| THRD | Third Harmonic Bio Inc | $241.86M | -9.01% |
| CDXS | Codexis Inc | $239.96M | -9.73% |
| VYGR | Voyager Therapeutics Inc | $237.02M | -10.83% |
| ADAG | Adagene Inc | $236.93M | -10.87% |
| NKTX | Nkarta Inc | $236.88M | -10.88% |
| GNFT | GENFIT S.A. American Depositary Shares | $233.01M | -12.34% |
| OBIO | Orchestra BioMed Holdings Inc | $231.59M | -12.88% |
| NERV | Minerva Neurosciences Inc | $230.61M | -13.25% |
| SLRN | Acelyrin Inc | $228.54M | -14.02% |
| WHWK | Whitehawk Therapeutics Inc | $225.60M | -15.13% |
| IKT | Inhibikase Therapeutics Inc | $224.46M | -15.56% |
| CRBU | Caribou Biosciences Inc | $223.96M | -15.75% |
| KROS | Keros Therapeutics Inc | $223.18M | -16.04% |
| RNA | Atrium Therapeutics Inc | $222.37M | -16.34% |
| CAMP | CAMP4 Therapeutics Corp | $218.61M | -17.76% |
| ARCT | Arcturus Therapeutics Holdings Inc | $217.72M | -18.09% |
| SLGL | Sol-Gel Technologies Ltd | $205.59M | -22.66% |
| KPTI | Karyopharm Therapeutics Inc | $202.45M | -23.84% |
| TLSA | Tiziana Life Sciences Ltd | $201.81M | -24.08% |
| ELTX | Elicio Therapeutics Inc | $200.75M | -24.48% |
| KRRO | Korro Bio Inc | $198.45M | -25.34% |
| RNAC | Cartesian Therapeutics Inc | $197.81M | -25.58% |
| DTIL | Precision Biosciences Inc | $195.87M | -26.32% |
| IMUX | Immunic Inc | $190.70M | -28.26% |
| QTTB | Q32 Bio Inc | $187.99M | -29.28% |
| ENLV | Enlivex Therapeutics Ltd | $185.63M | -30.17% |
| MDWD | MediWound Ltd | $184.49M | -30.60% |
| ABOS | Acumen Pharmaceuticals Inc | $183.46M | -30.98% |
| THAR | Tharimmune Inc | $183.00M | -31.16% |
| IFRX | InflaRx N.V. | $182.18M | -31.46% |
| SGMT | Sagimet Biosciences Inc - Class A | $180.81M | -31.98% |
| UNCY | Unicycive Therapeutics Inc | $178.43M | -32.87% |
| GALT | Galectin Therapeutics Inc | $177.81M | -33.11% |
| ACHV | Achieve Life Sciences Inc | $173.54M | -34.71% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | $172.60M | -35.07% |
| TNXP | Tonix Pharmaceuticals Holding Corp | $172.60M | -35.07% |
| HRTX | Heron Therapeutics Inc | $172.54M | -35.09% |
| TNYA | Tenaya Therapeutics Inc | $171.88M | -35.34% |
| RANI | Rani Therapeutics Holdings Inc Class A | $171.00M | -35.67% |
| SPRO | Spero Therapeutics Inc | $169.62M | -36.19% |
| PLX | Protalix BioTherapeutics Inc | $169.28M | -36.32% |
| THTX | Theratechnologies Inc | $167.34M | -37.05% |
| ANTX | AN2 Therapeutics Inc | $166.61M | -37.32% |
| EQ | Equillium Inc | $166.29M | -37.44% |
| MIST | Milestone Pharmaceuticals Inc | $164.91M | -37.96% |
| PRQR | ProQR Therapeutics N.V | $164.37M | -38.17% |
| MENS | Jyong Biotech Ltd | $164.22M | -38.22% |
| ORMP | Oramed Pharmaceuticals Inc | $162.89M | -38.72% |
| IPHA | Innate Pharma | $159.97M | -39.82% |
| TTRX | Turn Therapeutics Inc | $157.58M | -40.72% |
| MOLN | Molecular Partners AG | $154.89M | -41.73% |
| VXRT | Vaxart Inc | $153.61M | -42.21% |
| HURA | TuHURA Biosciences Inc | $151.32M | -43.07% |
| NBP | NovaBridge Biosciences. | $150.91M | -43.23% |
| CNTB | Connect Biopharma Holdings Ltd | $150.51M | -43.38% |
| AKTX | Akari Therapeutics Plc | $148.12M | -44.28% |
| MRSN | Mersana Therapeutics Inc | $145.36M | -45.32% |
| INDP | Indaptus Therapeutics Inc | $143.82M | -45.90% |
| NRXP | NRX Pharmaceuticals Inc | $143.26M | -46.11% |
| PROK | ProKidney Corp - Class A | $137.85M | -48.14% |
| TCRX | Tscan Therapeutics Inc | $137.63M | -48.23% |
| GNLX | Genelux Corp | $137.21M | -48.38% |
| GUTS | Fractyl Health Inc | $136.31M | -48.72% |
| BDTX | Black Diamond Therapeutics Inc | $132.37M | -50.20% |
| AGEN | Agenus Inc | $131.36M | -50.58% |
| ACOG | Alpha Cognition Inc | $124.77M | -53.06% |
| CRDF | Cardiff Oncology Inc | $123.75M | -53.45% |
| KLRS | Kalaris Therapeutics Inc | $120.48M | -54.68% |
| NTHI | NeOnc Technologies Holdings Inc | $120.03M | -54.84% |
| SEER | Seer Inc - Class A | $115.64M | -56.50% |
| ENGN | enGene Holdings Inc | $115.22M | -56.65% |
| RPTX | Repare Therapeutics Inc | $113.91M | -57.15% |
| COYA | Coya Therapeutics Inc | $111.89M | -57.91% |
| PYXS | Pyxis Oncology Inc | $108.70M | -59.11% |
| VANI | Vivani Medical Inc | $108.35M | -59.24% |
| CGTX | Cognition Therapeutics Inc | $106.33M | -60.00% |
| HLVX | HilleVax Inc | $104.74M | -60.60% |
| ONCY | Oncolytics Biotech Inc | $104.52M | -60.68% |
| VRCA | Verrica Pharmaceuticals Inc | $104.10M | -60.84% |
| ALDX | Aldeyra Therapeutics Inc | $103.15M | -61.20% |
| PEPG | PepGen Inc | $103.13M | -61.20% |
| ADVM | Adverum Biotechnologies Inc | $102.40M | -61.48% |
| BMEA | Biomea Fusion Inc | $98.33M | -63.01% |
| CBUS | Cibus Global Ltd. Class A | $97.80M | -63.21% |
| KZIA | Kazia Therapeutics Ltd | $97.74M | -63.23% |
| ICCC | Immucell Corp | $96.17M | -63.82% |
| PMN | ProMIS Neurosciences Inc | $93.94M | -64.66% |
| ATHA | Athira Pharma Inc | $92.15M | -65.33% |
| FBIO | Fortress Biotech Inc | $91.60M | -65.54% |
| PTHS | Channel Therapeutics Corporation | $90.85M | -65.82% |
| ATRA | Atara Biotherapeutics Inc | $89.72M | -66.25% |
| ANIX | Anixa Biosciences Inc | $88.68M | -66.64% |
| EXOZ | Invizyne Technologies Inc | $88.10M | -66.86% |
| INO | Inovio Pharmaceuticals Inc | $87.22M | -67.19% |
| AARD | Aardvark Therapeutics Inc | $87.05M | -67.25% |
| ADAP | Adaptimmune Therapeutics plc American Depositary Shares | $86.99M | -67.27% |
| PYPD | Polypid Ltd | $86.83M | -67.33% |
| NRXS | Neuraxis Inc | $85.30M | -67.91% |
| LPTX | Leap Therapeutics Inc | $84.76M | -68.11% |
| CSBR | Champions Oncology Inc | $82.35M | -69.02% |
| ACET | Adicet Bio Inc | $81.58M | -69.31% |
| HYFT | MindWalk Holdings Corp | $79.54M | -70.08% |
| MAIA | MAIA Biotechnology Inc | $79.48M | -70.10% |
| SGMO | Sangamo Therapeutics Inc | $77.92M | -70.69% |
| FBIOP | Fortress Biotech Inc | $77.72M | -70.76% |
| RLYB | Rallybio Corp | $76.87M | -71.08% |
| PLRX | Pliant Therapeutics Inc | $76.77M | -71.12% |
| GANX | Gain Therapeutics Inc | $75.20M | -71.71% |
| LIXT | Lixte Biotechnology Holdings Inc | $74.68M | -71.90% |
| XBIT | XBiotech Inc | $74.39M | -72.01% |
| OSTX | OS Therapies Inc | $74.24M | -72.07% |
| MCRB | Seres Therapeutics Inc | $73.19M | -72.47% |
| SAVA | Cassava Sciences Inc. | $72.46M | -72.74% |
| MNMD | Mind Medicine (MindMed) Inc. Common Shares | $71.93M | -72.94% |
| EDSA | Edesa Biotech Inc | $70.82M | -73.36% |
| BYSI | BeyondSpring Inc | $70.31M | -73.55% |
| ATHE | Alterity Therapeutics Ltd | $68.71M | -74.15% |
| SPRB | Spruce Biosciences Inc | $67.96M | -74.44% |
| CUE | Cue Biopharma Inc | $66.52M | -74.97% |
| IMA | Ikena Oncology Inc | $66.48M | -74.99% |
| MNOV | Medicinova Inc | $65.46M | -75.37% |
| IBIO | iBio Inc | $64.94M | -75.57% |
| ACRV | Acrivon Therapeutics Inc | $64.32M | -75.80% |
| PMVP | PMV Pharmaceuticals Inc | $64.00M | -75.92% |
| IMMP | Immutep Ltd | $63.92M | -75.95% |
| KLTO | Klotho Neurosciences Inc Com | $63.55M | -76.09% |
| OKYO | OKYO Pharma Ltd - New | $63.24M | -76.21% |
| ACHL | Achilles Therapeutics Plc | $63.22M | -76.22% |
| PDSB | PDS Biotechnology Corporation | $61.96M | -76.69% |
| OTLK | Outlook Therapeutics Inc | $61.25M | -76.96% |
| GLTO | Galecto Inc | $60.81M | -77.12% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | $59.20M | -77.73% |
| ANVS | Annovis Bio Inc | $57.22M | -78.47% |
| DWTX | Virios Therapeutics Inc | $57.12M | -78.51% |
| ENTX | Entera Bio Ltd | $55.48M | -79.13% |
| TIL | Instil Bio Inc | $55.21M | -79.23% |
| KZR | Kezar Life Sciences Inc | $53.76M | -79.78% |
| IBO | NYSE AMEX LISTED TEST STOCK FOR CTS CQS | $52.83M | -80.12% |
| MREO | Mereo Biopharma Group Plc | $52.71M | -80.17% |
| NBY | Stablecoin Development Corp | $52.10M | -80.40% |
| RNTX | Rein Therapeutics Inc | $51.79M | -80.51% |
| GOSS | Gossamer Bio Inc | $51.14M | -80.76% |
| MGX | Metagenomi Inc | $50.82M | -80.88% |
| ACTU | Actuate Therapeutics Inc | $50.03M | -81.18% |
| INKT | MiNK Therapeutics Inc | $48.84M | -81.63% |
| ESLA | Estrella Immunopharma Inc | $48.44M | -81.78% |
| XLO | Xilio Therapeutics Inc | $48.23M | -81.86% |
| CING | Cingulate Inc | $47.16M | -82.26% |
| ATYR | Atyr Pharma Inc | $46.89M | -82.36% |
| LVTX | LAVA Therapeutics NV | $45.77M | -82.78% |
| TELO | Telomir Pharmaceuticals Inc | $45.73M | -82.80% |
| PSTV | Plus Therapeutics Inc | $45.56M | -82.86% |
| ATOS | Atossa Therapeutics Inc | $44.09M | -83.41% |
| KALA | Kala Bio Inc | $43.31M | -83.71% |
| RNXT | RenovoRx Inc | $41.96M | -84.22% |
| NTRB | Nutriband Inc | $41.39M | -84.43% |
| HYPD | Eyenovia Inc | $41.14M | -84.52% |
| FGEN | FibroGen Inc | $39.31M | -85.21% |
| NNVC | NanoViricides Inc | $37.88M | -85.75% |
| VERU | Veru Inc | $37.40M | -85.93% |
| LTRN | Lantern Pharma Inc | $37.25M | -85.99% |
| INMB | INmune Bio Inc | $37.22M | -86.00% |
| ATNM | Actinium Pharmaceuticals Inc | $36.71M | -86.19% |
| RADX | Radiopharm Theranostics Ltd | $36.10M | -86.42% |
| GRCE | Acasti Pharma Inc | $36.05M | -86.44% |
| GBIO | Generation Bio Company | $35.97M | -86.47% |
| ABVC | ABVC BioPharma Inc | $35.82M | -86.53% |
| MURA | Mural Oncology plc | $35.34M | -86.70% |
| LITS | Lite Strategy Inc | $35.16M | -86.77% |
| ALGS | Aligos Therapeutics Inc | $34.65M | -86.96% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | $34.30M | -87.10% |
| DARE | Dare Bioscience Inc | $33.92M | -87.24% |
| EVAX | Evaxion Biotech A/S | $33.82M | -87.28% |
| BOLD | Boundless Bio Inc | $32.94M | -87.61% |
| SNTI | Senti Biosciences Inc | $31.46M | -88.17% |
| TVRD | Cara Therapeutics Inc | $30.96M | -88.35% |
| LSTA | Lisata Therapeutics Inc | $30.05M | -88.69% |
| TVGN | Tevogen Bio Holdings Inc | $29.97M | -88.72% |
| APLM | Apollomics Inc - Class A | $29.93M | -88.74% |
| NRSN | NeuroSense Therapeutics Ltd | $29.15M | -89.03% |
| SKYE | Skye Bioscience Inc | $29.10M | -89.05% |
| NEUP | Neuphoria Therapeutics Inc | $29.04M | -89.08% |
| GRDX | Entero Therapeutics Inc | $28.95M | -89.11% |
| BRNS | Barinthus Biotherapeutics Plc. | $28.59M | -89.25% |
| CRVO | CervoMed Inc | $28.15M | -89.41% |
| IGC | IGC Pharma Inc | $28.00M | -89.47% |
| DYAI | Dyadic International Inc DE | $27.40M | -89.69% |
| ALLR | Allarity Therapeutics Inc | $27.37M | -89.70% |
| SER | AgeX Therapeutics Inc | $26.82M | -89.91% |
| PLRZ | Polyrizon Ltd | $26.52M | -90.02% |
| CELU | Celularity Inc - Class A | $26.39M | -90.07% |
| VTGN | VistaGen Therapeutics Inc | $26.36M | -90.08% |
| BCTX | BriaCell Therapeutics Corp - New | $26.32M | -90.10% |
| PTN | Palatin Technologies Inc | $26.08M | -90.19% |
| TPST | Tempest Therapeutics Inc | $25.68M | -90.34% |
| JSPR | Jasper Therapeutics Inc | $25.26M | -90.50% |
| PLUR | Pluri Inc | $24.62M | -90.74% |
| MRKR | Marker Therapeutics Inc | $24.21M | -90.89% |
| HOWL | Werewolf Therapeutics Inc | $23.81M | -91.04% |
| VYNE | VYNE Therapeutics Inc | $22.68M | -91.47% |
| SNSE | Sensei Biotherapeutics Inc | $22.32M | -91.60% |
| HOTH | Hoth Therapeutics Inc | $22.13M | -91.68% |
| COEP | Coeptis Therapeutics Holdings Inc. Common Stock | $21.96M | -91.74% |
| NXTC | Nextcure Inc | $21.90M | -91.76% |
| OPT | Opthea Ltd | $21.53M | -91.90% |
| CRIS | Curis Inc | $21.11M | -92.06% |
| PHXM | PHAXIAM Therapeutics SA ADR | $20.38M | -92.33% |
| LGVN | Longeveron Inc - Class A | $19.70M | -92.59% |
| GNTA | Genenta Science SpA | $19.23M | -92.77% |
| AEON | AEON Biopharma Inc - Class A | $19.22M | -92.77% |
| ANEB | Anebulo Pharmaceuticals, Inc. Common Stock | $18.90M | -92.89% |
| XCUR | Exicure Inc | $17.78M | -93.31% |
| INAB | IN8bio Inc | $17.72M | -93.33% |
| PASG | Passage Bio Inc | $17.71M | -93.34% |
| KTTA | Pasithea Therapeutics Corp | $17.28M | -93.50% |
| MTVA | MetaVia Inc | $17.25M | -93.51% |
| LPCN | Lipocine Inc | $17.04M | -93.59% |
| NCEL | NLS Pharmaceutics Ltd | $16.55M | -93.77% |
| OSRH | Bellevue Life Sciences Acquisition Corp | $16.12M | -93.94% |
| HIND | ReShape Lifesciences Inc | $15.72M | -94.09% |
| COCP | Cocrystal Pharma Inc | $15.44M | -94.19% |
| CTXR | Citius Pharmaceuticals Inc | $15.44M | -94.19% |
| LEXX | Lexaria Bioscience Corp | $15.24M | -94.27% |
| CLRB | Cellectar Biosciences Inc | $14.97M | -94.37% |
| QNCX | Quince Therapeutics Inc | $14.89M | -94.40% |
| APLT | Applied Therapeutics Inc | $14.86M | -94.41% |
| HOOK | Hookipa Pharma Inc | $14.68M | -94.48% |
| BLRX | Bioline Rx Ltd | $14.66M | -94.48% |
| MBRX | Moleculin Biotech Inc | $14.57M | -94.52% |
| IOBT | IO Biotech Inc | $14.50M | -94.55% |
| ICU | SeaStar Medical Holding Corp | $14.34M | -94.61% |
| GDTC | CytoMed Therapeutics Ltd | $14.15M | -94.68% |
| GTBP | GT Biopharma Inc | $13.91M | -94.77% |
| CMMB | Chemomab Therapeutics Ltd | $13.67M | -94.86% |
| TOVX | Theriva Biologics Inc | $13.51M | -94.92% |
| CYCN | Cyclerion Therapeutics Inc | $13.36M | -94.97% |
| LSB | LakeShore Biopharma Co Ltd | $13.02M | -95.10% |
| ERNA | Ernexa Therapeutics Inc | $12.99M | -95.11% |
| PHIO | Phio Pharmaceuticals Corp | $12.78M | -95.19% |
| CVKD | Cadrenal Therapeutics Inc | $12.33M | -95.36% |
| CALC | CalciMedica Inc | $11.72M | -95.59% |
| LNAI | Lunai Bioworks Inc | $11.72M | -95.59% |
| TRAW | Traws Pharma Inc | $11.70M | -95.60% |
| INTS | Intensity Therapeutics Inc | $11.33M | -95.74% |
| BIVI | BioVie Inc - Class A | $11.16M | -95.80% |
| KPRX | Kiora Pharmaceuticals Inc | $11.14M | -95.81% |
| BRTX | BioRestorative Therapies Inc | $11.03M | -95.85% |
| APRE | Aprea Therapeutics Inc | $10.96M | -95.88% |
| KAPA | Kairos Pharma Ltd | $10.68M | -95.98% |
| KLTOW | Klotho Neurosciences Inc Wt Exp | $10.43M | -96.08% |
| CVM | Cel-Sci Corp | $10.15M | -96.18% |
| BOLT | Bolt Biotherapeutics Inc | $10.13M | -96.19% |
| MLEC | Moolec Science SA | $10.06M | -96.22% |
| BCDA | BioCardia Inc | $9.85M | -96.29% |
| QNRX | Quoin Pharmaceuticals Ltd | $9.81M | -96.31% |
| CURX | Curanex Pharmaceuticals Inc | $9.73M | -96.34% |
| SNGX | Soligenix Inc | $9.11M | -96.57% |
| IMNN | Imunon Inc | $9.02M | -96.61% |
| EPIX | Essa Pharma Inc | $8.93M | -96.64% |
| SONN | Sonnet BioTherapeutics Holdings Inc | $8.92M | -96.65% |
| CANF | Can-Fite Biopharma Ltd | $8.80M | -96.69% |
| JUNS | Jupiter Neurosciences Inc | $8.70M | -96.73% |
| CELZ | Creative Medical Technology Holdings Inc | $8.54M | -96.79% |
| IMRN | Immuron Ltd | $8.36M | -96.86% |
| PMCB | PharmaCyte Biotech Inc | $8.16M | -96.93% |
| LIMN | Liminatus Pharma Inc | $8.08M | -96.96% |
| ITRM | Iterum Therapeutics Plc | $8.06M | -96.97% |
| NCNA | NuCana plc | $7.95M | -97.01% |
| ADXN | Addex Therapeutics Ltd | $7.90M | -97.03% |
| SYBX | Synlogic Inc | $7.72M | -97.10% |
| BCLI | Brainstorm Cell Therapeutics Inc | $7.66M | -97.12% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | $7.34M | -97.24% |
| XBIO | Xenetic Biosciences Inc | $7.06M | -97.34% |
| GNPX | Genprex Inc | $7.02M | -97.36% |
| ASBP | Aspire Biopharma Holdings Inc | $6.98M | -97.37% |
| EVGN | Evogene Ltd | $6.91M | -97.40% |
| SILO | SILO Pharma Inc | $6.78M | -97.45% |
| ACXP | Acurx Pharmaceuticals Inc | $6.74M | -97.46% |
| TCRT | Alaunos Therapeutics Inc | $6.68M | -97.49% |
| PCSA | Processa Pharmaceuticals Inc | $6.40M | -97.59% |
| GOVX | Geovax Labs Inc | $6.29M | -97.64% |
| APM | Aptorum Group Ltd - Class A | $6.26M | -97.65% |
| BCAB | BioAtla Inc | $6.19M | -97.67% |
| PPBT | Purple Biotech Ltd | $6.05M | -97.72% |
| APVO | Aptevo Therapeutics Inc | $5.83M | -97.81% |
| BGMS | Bio Green Med Solution Inc | $5.30M | -98.01% |
| CLGN | CollPlant Biotechnologies Ltd New | $5.25M | -98.02% |
| DRMA | Dermata Therapeutics Inc | $5.23M | -98.03% |
| CDIO | Cardio Diagnostics Holdings Inc | $5.18M | -98.05% |
| HCWB | HCW Biologics Inc | $5.10M | -98.08% |
| PULM | Pulmatrix Inc | $4.97M | -98.13% |
| TTNP | Titan Pharmaceuticals Inc (de) | $4.91M | -98.15% |
| RVPH | Reviva Pharmaceuticals Holdings Inc | $4.91M | -98.15% |
| MTNB | Matinas Biopharma Holdings Inc | $4.68M | -98.24% |
| RNAZ | TransCode Therapeutics Inc | $4.67M | -98.24% |
| ALZN | Alzamend Neuro Inc | $4.38M | -98.35% |
| MBIO | Mustang Bio Inc | $4.29M | -98.39% |
| CASI | CASI Pharmaceuticals Inc | $4.27M | -98.40% |
| ENTO | Entero Therapeutics, Inc. Common Stock | $4.26M | -98.40% |
| REVB | Revelation Biosciences Inc | $4.26M | -98.40% |
| FBLG | FibroBiologics Inc | $4.23M | -98.41% |
| ENVB | Enveric Biosciences Inc | $4.15M | -98.44% |
| CNSP | Cns Pharmaceuticals Inc | $4.14M | -98.44% |
| GLMD | Galmed Pharmaceuticals Ltd | $4.08M | -98.46% |
| PHGE | BiomX Inc | $3.91M | -98.53% |
| PBM | Psyence Biomedical Ltd | $3.76M | -98.58% |
| SXTP | 60 Degrees Pharmaceuticals Inc | $3.72M | -98.60% |
| ADIL | Adial Pharmaceuticals Inc | $3.61M | -98.64% |
| VIVS | VivoSim Labs Inc | $3.36M | -98.73% |
| XRTX | XORTX Therapeutics Inc | $3.34M | -98.74% |
| AZTR | Azitra Inc | $3.32M | -98.75% |
| GRI | GRI Bio Inc | $3.30M | -98.76% |
| SPRC | SciSparc Ltd | $3.05M | -98.85% |
| AFMD | Affimed N.V. | $2.98M | -98.88% |
| CMND | Clearmind Medicine Inc | $2.88M | -98.92% |
| ENSC | Ensysce Biosciences Inc | $2.88M | -98.92% |
| ARTL | Artelo Biosciences Inc | $2.75M | -98.97% |
| OGEN | Oragenics Inc | $2.58M | -99.03% |
| PPCB | Propanc Biopharma Inc | $2.50M | -99.06% |
| NTBL | Notable Labs Inc Ord | $2.39M | -99.10% |
| BBLG | Bone Biologics Corp | $2.23M | -99.16% |
| CLSD | Clearside Biomedical, Inc. Common Stock | $2.15M | -99.19% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | $2.09M | -99.21% |
| CLDI | Calidi Biotherapeutics Inc | $1.99M | -99.25% |
| AIM | AIM ImmunoTech Inc. | $1.74M | -99.34% |
| ONCO | Onconetix Inc | $1.61M | -99.39% |
| ONCT | Oncternal Therapeutics Inc | $1.56M | -99.41% |
| ZVSA | ZyVersa Therapeutics Inc | $1.55M | -99.42% |
| SCNI | Scinai Immunotherapeutics Ltd | $1.55M | -99.42% |
| VRAX | Virax Biolabs Group Ltd - Class A | $1.52M | -99.43% |
| ABP | Abpro Holdings, Inc Common Stock | $1.43M | -99.46% |
| LYRA | Lyra Therapeutics Inc | $1.38M | -99.48% |
| JAGX | Jaguar Health Inc | $1.34M | -99.49% |
| SLXN | Silexion Therapeutics Corp | $1.30M | -99.51% |
| PTIX | Protagenic Therapeutics Inc | $1.01M | -99.62% |
| BDRX | Biodexa Pharmaceuticals Plc | $919907.57 | -99.65% |
| TNFA | TNF Pharmaceuticals Inc | $551031.39 | -99.79% |
| SLRX | Decoy Therapeutics Inc | $446853.12 | -99.83% |
| ELAB | PMGC Holdings Inc | $221376.00 | -99.92% |
| ADTX | Aditxt Inc | $132564.52 | -99.95% |
| CDT | CDT Equity Inc | $110551.31 | -99.96% |